Your browser doesn't support javascript.
loading
What is the role of combination drug therapy in the treatment of overactive bladder? ICI-RS 2014.
Visco, Anthony G; Fraser, Matthew O; Newgreen, Donald; Oelke, Matthias; Cardozo, Linda.
Afiliação
  • Visco AG; Division of Urogynecology and Reconstructive Pelvic Surgery, Duke University Medical Center, Durham, North Carolina.
  • Fraser MO; Department of Surgery, Division of Urology, Duke University Medical Center, Durham, North Carolina.
  • Newgreen D; Global Medical Science - Urology/ Nephrology, Astellas Pharma Global Development, Leiden, The Netherlands.
  • Oelke M; Department of Urology, Functional & Reconstructive Urology, Hannover Medical School, Hannover, Germany.
  • Cardozo L; Department of Urogynaecology, King's College Hospital, London, United Kingdom.
Neurourol Urodyn ; 35(2): 288-92, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26872569
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bexiga Urinária / Antagonistas Muscarínicos / Bexiga Urinária Hiperativa Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Neurourol Urodyn Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bexiga Urinária / Antagonistas Muscarínicos / Bexiga Urinária Hiperativa Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Neurourol Urodyn Ano de publicação: 2016 Tipo de documento: Article